A Rare Case of Peritoneal Disseminated Angiosarcoma 20 Years after Ovarian Cancer Diagnosis

被引:3
作者
Chudecka-Glaz, Anita [1 ,2 ]
Menkiszak, Janusz [1 ,2 ]
Kuzniak, Slawomir [1 ,2 ]
Lewandowska, Magdalena [3 ]
Burak, Miroslaw [4 ]
Walecka, Anna [4 ]
机构
[1] Pomeranian Med Univ, Dept Gynecol Surg, Szczecin, Poland
[2] Pomeranian Med Univ, Dept Gynecol Oncol Adults & Adolescents, Szczecin, Poland
[3] Pomeranian Med Univ, Dept Pathol, Szczecin, Poland
[4] Pomeranian Med Univ, Dept Diagnost Imaging & Intervent Radiol, Szczecin, Poland
关键词
Postirradiation tumors; Angiosarcoma; Ovarian cancer; HE4; marker;
D O I
10.1159/000356690
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Angiosarcoma is a rare form of sarcoma which may be either a primary tumor or it may result from previous irradiation because of another tumor. In this paper, we present a case of a female patient diagnosed as having peritoneal disseminated angiosarcoma 20 years after ovarian cancer treatment (surgery, chemotherapy and radiotherapy). The case was very atypical because of an extremely rare peritoneal location and disseminated nature of the changes. Based on the initial histological picture, poorly differentiated cancer metastasis was diagnosed, suggesting a recurrence of the ovarian cancer that had been diagnosed earlier. The time elapsed from the ovarian cancer diagnosis, history of the previous irradiation and concentration of tumor markers were the only additional clinical data provided to the pathologists, which ultimately contributed to a correct diagnosis. The case we present herein shows and emphasizes the importance of proper communication between a clinician and a pathologist, which is a prerequisite for a correct diagnosis and, consequently, for proper treatment of patients. It also confirms the high specificity of the HE4 (human epididymis protein 4) marker in the monitoring of ovarian cancer, which was within normal limits in spite of peritoneal tumor dissemination. (C) 2013 S. Karger AG, Basel
引用
收藏
页码:68 / 72
页数:5
相关论文
共 17 条
  • [1] Cahan WG, 1998, CANCER-AM CANCER SOC, V82, P8, DOI 10.1002/(SICI)1097-0142(19980101)82:1<8::AID-CNCR3>3.0.CO
  • [2] 2-W
  • [3] Espat N J, 2000, Sarcoma, V4, P173, DOI 10.1080/13577140020025896
  • [4] Food and Drug Administration, 510 K SUBST EQ DET D
  • [5] Consistent MYC and FLT4 Gene Amplification in Radiation-Induced Angiosarcoma But Not in Other Radiation-Associated Atypical Vascular Lesions
    Guo, Tianhua
    Zhang, Lei
    Chang, Ning-En
    Singer, Samuel
    Maki, Robert G.
    Antonescu, Cristina R.
    [J]. GENES CHROMOSOMES & CANCER, 2011, 50 (01) : 25 - 33
  • [6] Hornick JL, 2002, AM J CLIN PATHOL, V117, P188
  • [7] Khalil Maged F., 2005, Sarcoma, V9, P161, DOI 10.1080/13577140500389069
  • [8] Lewis J J, 1996, Curr Probl Surg, V33, P817
  • [9] Malignant vascular tumors of the serous membranes mimicking mesothelioma - A report of 14 cases
    Lin, BTY
    Colby, T
    Gown, AM
    Hammar, SP
    Mertens, RB
    Churg, A
    Battifora, H
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (12) : 1431 - 1439
  • [10] MYC High Level Gene Amplification Is a Distinctive Feature of Angiosarcomas after Irradiation or Chronic Lymphedema
    Manner, Johanna
    Radlwimmer, Bernhard
    Hohenberger, Peter
    Moessinger, Katharina
    Kueffer, Stefan
    Sauer, Christian
    Belharazem, Djeda
    Zettl, Andreas
    Coindre, Jean-Michel
    Hallermann, Christian
    Hartmann, Joerg Thomas
    Katenkamp, Detlef
    Katenkamp, Kathrin
    Schoeffski, Patrick
    Sciot, Raf
    Wozniak, Agnieszka
    Lichter, Peter
    Marx, Alexander
    Stroebel, Philipp
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (01) : 34 - 39